Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Nexalin Technology Inc (NASDAQ: NXL) was $0.56 for the day, up 2.50% from the previous closing price of $0.54. In other words, the price has increased by $2.50 from its previous closing price. On the day, 0.34 million shares were traded. NXL stock price reached its highest trading level at $0.64 during the session, while it also had its lowest trading level at $0.54.
Ratios:
Our analysis of NXL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.03 and its Current Ratio is at 13.47. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 10 ’25 when Elson Marilyn bought 23,150 shares for $0.02 per share.
Shelton Carolyn Hamby bought 6,000 shares of NXL for $13,200 on Mar 12 ’25. The Sr. VP – Quality, Regulatory now owns 30,000 shares after completing the transaction at $2.20 per share. On Feb 04 ’25, another insider, Owens David, who serves as the Chief Medical Officer of the company, bought 1,000 shares for $3.10 each. As a result, the insider paid 3,100 and bolstered with 155,793 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NXL now has a Market Capitalization of 10407783 and an Enterprise Value of 6055105. For the stock, the TTM Price-to-Sale (P/S) ratio is 65.02 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 38.585 whereas that against EBITDA is -0.685.
Stock Price History:
The Beta on a monthly basis for NXL is 3.92, which has changed by -0.8305296 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, NXL has reached a high of $3.87, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is -48.40%, while the 200-Day Moving Average is calculated to be -53.78%.
Shares Statistics:
NXL traded an average of 3.55M shares per day over the past three months and 248940 shares per day over the past ten days. A total of 18.19M shares are outstanding, with a floating share count of 14.40M. Insiders hold about 22.82% of the company’s shares, while institutions hold 3.73% stake in the company. Shares short for NXL as of 1765756800 were 50851 with a Short Ratio of 0.01, compared to 1763078400 on 273905. Therefore, it implies a Short% of Shares Outstanding of 50851 and a Short% of Float of 0.31.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.12. Analysts are recommending an EPS of between -$0.49 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.39, with 1.0 analysts recommending between -$0.39 and -$0.39.
Revenue Estimates
It is expected that $90B in revenue will be generated in . The current quarter, according to 1 analysts. It ranges from a high estimate of $80k to a low estimate of $80k. As of . The current estimate, Nexalin Technology Inc’s year-ago sales were $27.18kFor the next quarter, 1 analysts are estimating revenue of $100k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $100k.
A total of 1 analysts have provided revenue estimates for NXL’s current fiscal year. The highest revenue estimate was $231k, while the lowest revenue estimate was $231k, resulting in an average revenue estimate of $231k. In the same quarter a year ago, actual revenue was $168.72kBased on 1 analysts’ estimates, the company’s revenue will be $660k in the next fiscal year. The high estimate is $660k and the low estimate is $660k.
